Industry News
Xperential Scientific opens in Melbourne
Xperential Scientific is a newly established scientific instrumentation, consumable, software and diagnostic supplier based in Melbourne. [ + ]
Controlling protein synthesis with light
Japanese researchers have shown that they can prevent protein synthesis reactions from taking place using a photoresponsive molecular cage. [ + ]
Epilepsy drug now available for tonic-clonic seizures
Fycompa, a once-daily epilepsy treatment, is now available in Australia for adjunctive treatment of primary generalised tonic-clonic (PGTC) seizures in adults and adolescents with idiopathic generalised epilepsy. [ + ]
Call for increased collaboration and commercialisation
Bill Ferris AC, chair of Innovation and Science Australia, has called for greater collaboration between Australian businesses and our publicly funded research institutions. [ + ]
International BioFest 2016 is coming to Melbourne
From 24–27 October 2016, Melbourne Convention Centre will play host to International BioFest — a series of three major life sciences conferences taking place at the one time. [ + ]
Bio21 and Thermo Fisher collaborate on mass spectrometry laboratory
The University of Melbourne's Bio21 Institute has announced a major collaborative agreement with Thermo Fisher Scientific, a world leader in serving science through the development and provision of cutting-edge technology. [ + ]
New venture capital fund for Australian healthcare start-ups
BioScience Managers has announced the launch of a new venture capital fund for Australia's innovative healthcare and biomedical research sectors. [ + ]
A blood test to detect breast cancer
Australian and French scientists are developing a new potential way to detect and monitor breast cancer that could involve a simple blood test. [ + ]
Peanut allergy treatment gets a $15 million boost
OneVentures will lead a $15 million funding round for a promising new treatment for peanut allergy in children, developed at the Murdoch Childrens Research Institute. [ + ]
Defibrillator market put through the paces
Allied Market Research has projected that the global defibrillator market will reach $15.61 billion by 2022. [ + ]
A new way to find weakness in the Earth's crust
US and Australian scientists have developed a new method to estimate weakness in the Earth's outer layers. Their work will help explain and predict volcanic activity and earthquakes at a much smaller scale than previously possible. [ + ]
The secret to stopping malaria lies in the liver
Australian scientists have identified a new type of immune cell that stays in the liver — liver-resident immune cells — guarding against malaria infection. [ + ]
R&D Tax Incentive Review report released for consultation
The Turnbull government has announced the findings of the R&D Tax Incentive Review and is now encouraging feedback from stakeholders. [ + ]
CCS laboratories opened in Victoria
CO2CRC, The University of Melbourne and Federation University Australia have opened emissions reduction laboratories aimed at providing clean, efficient energy for Australia. [ + ]
Controlling stem cells in the lab
Scottish scientists have discovered a way to replicate the regenerative power of stem cells in the lab, preventing them from differentiating over a prolonged period. [ + ]
